Search Results for: BiomX

Exits, takeovers and mergers – to 10/3/24

Israel’s Deel is acquiring Africa’s PaySpace for around $100 million. US giant CrowdStrike, which already has acquired several Israeli startups has just acquired Israel’s Flow Security for around $200 million. Israeli phage therapy company BiomX is to merge with US-based … Continue reading

Posted in Economy & Business | Leave a comment

Orphan status for cystic fibrosis treatment

The US FDA has granted “orphan” status on BX004 from Israel’s BiomX (see here previously) for the treatment of chronic lung infections suffered by cystic fibrosis patients. Orphan designation is given for rare conditions that have no current treatment. https://ir.biomx.com/news-events/press-releases/detail/101/biomx-receives-orphan-drug-designation-from-the-u-s-food

Posted in Israel's Medical Achievements | Leave a comment

Positive trials of cystic fibrosis treatment

Israel’s BiomX (see here previously) has reported positive initial results from its clinical trials of BX004. The treatment relieves chronic pulmonary infections in patients with cystic fibrosis. BiomX now plans to initiate a larger Phase 2/3 trial. https://ir.biomx.com/news-events/press-releases/detail/99/biomx-announces-positive-topline-results-from-part-2-of-the

Posted in Israel's Medical Achievements | Leave a comment

Gut reaction in treating IBD

I reported previously (see here) on BiomX. The Israeli biotech has now partnered with Janssen – the therapy R&D arm of Johnson & Johnson. BiomX’s XMarker microbiome-based platform will be used to classify responders to inflammatory bowel disease (IBD) therapies. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Israeli biotechs merge

I reported previously (28th May) on Israeli biotech BiomX which develops treatments using human bacteria (microbiome).  BiomX has now acquired Israel’s RondinX, which has built a cutting-edge technology platform set to unlock the potential of microbiome therapeutics. http://www.globes.co.il/en/article-biomx-buys-rondinx-in-israeli-microbiome-merger-1001216994

Posted in Israel's Medical Achievements | Leave a comment

Using human bacteria to treat diseases

Israeli biotech BiomX is developing a pipeline of treatments for unmet medical needs, including cancer, inflammatory bowel disease and acne.  BiomX focuses on modulating the human microbiome – bacteria that reside in and on the human body – to boost … Continue reading

Posted in Israel's Medical Achievements | 1 Comment